Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost recent
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

AstraZeneca ends phase 3 lung cancer drug trial

Digest more
Top News
Overview
 · 1d
AstraZeneca halts lung cancer trial in fresh pipeline setback
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported positive results from a late-stage trial of a two-drug combination for a hard-to-treat form of lung cancer, potentially opening the way to approval a...

Continue reading

 · 1d · on MSN
AstraZeneca suffers another setback as it halts volrustomig lung cancer trial
BioPharma Dive · 1d
AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer
 · 1d
AstraZeneca lung cancer drug combination extends survival in trial
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported positive results from a late-stage trial of a two-drug combination for a hard-to-treat form of lung cancer, potentially opening the way to approval a...

Continue reading

 · 1d
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
 · 1d
AstraZeneca to discontinue late-stage lung cancer trial for volrustomig
3h

New robotic procedure to test for lung cancer comes to Galesburg

The rate of new lung cancer cases in both Iowa and Illinois is higher than the national average. In numbers from 2025, the American Lung Association reports that Iowa has 60.3 new cases for every
Fierce Pharma
15h

Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test

Biokin Pharma’s iza-bren, a first-in-class antibody-drug conjugate partnered with Bristol Myers Squibb, has posted another positive phase 3 readout. | Biokin Pharma’s iza-bren, a first-in-class antibody-drug conjugate partnered with Bristol Myers Squibb,
14d

New therapy shrinks tumors to treat lung cancer

The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in the United States. New findings by a research team from the Stony Brook Cancer Center highlight a novel therapeutic shown to be highly effective in reducing non-small cell lung cancer (NSCLC) tumors and appearing to halt drug resistance in a laboratory model.
42mon MSN

From kitchen smoke to traffic fumes: Are Indians underestimating everyday lung cancer risks linked to air pollution?

Lung cancer in India is rising not just due to smoking but also from everyday air pollution. Doctors warn that kitchen smoke, traffic fumes and industrial dust can damage lung tissue, trigger inflammation and raise cancer risk.
WebMD
5mon

Lung Adenocarcinoma: Symptoms, Causes, and Treatment

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung cancer, or have an adenocarcinoma, can be a challenge.
Medscape
2d

Cigar and Pipe Smoking Increases Risk for Lung Cancer and Elevates Screening Needs

Current or former use of cigars, cigarillos, or pipes increases the risk for lung cancer and may make more people eligible for low-dose CT screening, a study shows.
  • Privacy
  • Terms